No Data
No Data
No Data
Jiangsu Recbio Technology Shareholders to Vote Dec. 24 on Share Issue
Express News | Jiangsu Recbio Technology - to Issue Not More Than 143.1 Mln Domestic Shares at RMB5.59 per Share
Jiangsu Recbio Technology Initiates Phase III Clinical Trials for Shingles Vaccine
Jiangsu Recbio Technology Co., Ltd. (HKG:2179) Surges 12%; Individual Investors Who Own 24% Shares Profited Along With Institutions
Express News | Jiangsu Recbio Technology - Hy Loss Attributable RMB247.7 Mln Vs Loss RMB269.1 Mln
Express News | Jiangsu Recbio Technology H1 Capex RMB 78.1 Million
No Data
whqqq : Will they fall after a pandemic?
Spinee OP whqqq : It's hard to say
whqqq Spinee OP : But it can still be held for a short time, right?